Debra A. Goff

11.4k total citations · 1 hit paper
114 papers, 3.6k citations indexed

About

Debra A. Goff is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases and Clinical Biochemistry. According to data from OpenAlex, Debra A. Goff has authored 114 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Applied Microbiology and Biotechnology, 34 papers in Infectious Diseases and 27 papers in Clinical Biochemistry. Recurrent topics in Debra A. Goff's work include Antibiotic Use and Resistance (57 papers), Bacterial Identification and Susceptibility Testing (27 papers) and Antibiotic Resistance in Bacteria (26 papers). Debra A. Goff is often cited by papers focused on Antibiotic Use and Resistance (57 papers), Bacterial Identification and Susceptibility Testing (27 papers) and Antibiotic Resistance in Bacteria (26 papers). Debra A. Goff collaborates with scholars based in United States, South Africa and United Kingdom. Debra A. Goff's co-authors include Karri A. Bauer, Julie E. Mangino, Jessica E. West, Ravina Kullar, Kurt Stevenson, Preeti Pancholi, Dena van den Bergh, Michael J. Rybak, Katherine K. Perez and Graeme N. Forrest and has published in prestigious journals such as SHILAP Revista de lepidopterología, Applied and Environmental Microbiology and Clinical Infectious Diseases.

In The Last Decade

Debra A. Goff

113 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ISUOG Practice Guidelines (updated): fetal cardiac screening

2023 73 citations Debra A. Goff et al. profile →

Peers

Countries citing papers authored by Debra A. Goff

Since Specialization

Citations

This map shows the geographic impact of Debra A. Goff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debra A. Goff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debra A. Goff more than expected).

Fields of papers citing papers by Debra A. Goff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debra A. Goff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debra A. Goff. The network helps show where Debra A. Goff may publish in the future.

Co-authorship network of co-authors of Debra A. Goff

This figure shows the co-authorship network connecting the top 25 collaborators of Debra A. Goff. A scholar is included among the top collaborators of Debra A. Goff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debra A. Goff. Debra A. Goff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antimicrobial stewardship interventions reduce the time to the first antibiotic administration in septic patients in ICUs: regional multicenter study in 7 Latin American high-complexity hospitals 2025 ·Antimicrobial Agents and Chemotherapy ·(unknown), Christian Pallares, (unknown), Elsa De La Cadena, Wanda Cornistein, (unknown), (unknown), (unknown), (unknown), (unknown), Paulo Castañeda-Méndez, (unknown), (unknown), (unknown), Vanessa Moreno, Debra A. Goff, María Virginia Villegas	0
2	Global collaborations in antimicrobial stewardship: All hands on deck 2023 ·SHILAP Revista de lepidopterología ·Diane Ashiru‐Oredope, Bradley J. Langford, Candice Bonaconsa, Vrinda Nampoothiri, Esmita Charani, Debra A. Goff	12
3	Gaps and barriers in the implementation and functioning of antimicrobial stewardship programmes: results from an educational and behavioural mixed-methods needs assessment in France, the United States, Mexico and India—authors’ response 2023 ·JAC-Antimicrobial Resistance ·(unknown), (unknown), Debra A. Goff, María Virginia Villegas, Anucha Apisarnthanarak, (unknown)	1
4	Private Practice Dentists Improve Antibiotic Use After Dental Antibiotic Stewardship Education From Infectious Diseases Experts 2022 ·Open Forum Infectious Diseases ·Debra A. Goff, Julie E. Mangino, (unknown), (unknown), (unknown), (unknown)	14
5	Opportunities for antimicrobial stewardship among carbapenem-treated patients in 18 North American hospitals 2020 ·International Journal of Antimicrobial Agents ·Jamie L. Wagner, Nathaniel J. Rhodes, Marc H. Scheetz, John A. Bosso, Debra A. Goff, Michael J. Rybak, Susan L. Davis	8
6	Sustainable Access to Antimicrobials; A Missing Component to Antimicrobial Stewardship—A Tale of Two Countries 2018 ·Frontiers in Public Health ·(unknown), (unknown), (unknown), Debra A. Goff, Natalie Schellack	12
7	Eight Habits of Highly Effective Antimicrobial Stewardship Programs to Meet the Joint Commission Standards for Hospitals 2017 ·Clinical Infectious Diseases ·Debra A. Goff, Ravina Kullar, Karri A. Bauer, Thomas M. File	50
8	Ceftriaxone Etest non-susceptible methicillin susceptible Staphylococcus aureus time-kill responses 2017 ·Diagnostic Microbiology and Infectious Disease ·Derek N. Bremmer, Joan-Miquel Balada-Llasat, Debra A. Goff, Karri A. Bauer	1
9	Engaging pharmacy personnel in antimicrobial stewardship using a novel method of teaching 2016 ·Pharmacy management ·(unknown), (unknown), Dena van den Bergh, Debra A. Goff	4
10	Approaches to Modifying the Behavior of Clinicians Who Are Noncompliant With Antimicrobial Stewardship Program Guidelines 2016 ·Clinical Infectious Diseases ·Ellie J. C. Goldstein, Debra A. Goff, (unknown), (unknown), Erin Epson, Jonathan M. Zenilman, Keith S. Kaye, Thomas M. File	28
11	Impact of rapid identification of Acinetobacter Baumannii via matrix-assisted laser desorption ionization time-of-flight mass spectrometry combined with antimicrobial stewardship in patients with pneumonia and/or bacteremia 2015 ·Diagnostic Microbiology and Infectious Disease ·Eric Wenzler, Debra A. Goff, Julie E. Mangino, Erica Reed, Allison Wehr, Karri A. Bauer	47
12	Antimicrobial Stewardship with Pharmacist Intervention Improves Timeliness of Antimicrobials Across Thirty-three Hospitals in South Africa 2015 ·Infectious Diseases and Therapy ·Angeliki Messina, Dena van den Bergh, Debra A. Goff	50
13	Minocycline: An Old Drug for a New Bug: Multidrug-Resistant Acinetobacter baumannii 2014 ·Clinical Infectious Diseases ·Debra A. Goff, Keith S. Kaye	17
14	Antimicrobial Salvage Therapy for Persistent Staphylococcal Bacteremia Using Daptomycin Plus Ceftaroline 2014 ·Clinical Therapeutics ·George Sakoulas, Pamela Moise, Anthony M. Casapao, Poochit Nonejuie, Joshua Olson, Cheryl Okumura, Michael J. Rybak, Ravina Kullar, Abhay Dhand, Warren E. Rose, Debra A. Goff, Adam Bressler, (unknown), Joseph Pogliano, Scott Johns, Glenn W. Kaatz, John R. Ebright, Victor Nizet	139
15	A Stewardship Program’s Retrospective Evaluation of Vancomycin AUC24/MIC and Time to Microbiological Clearance in Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia and Osteomyelitis 2013 ·Clinical Therapeutics ·(unknown), Debra A. Goff, Jack Brown, Tina Khadem, Karri A. Bauer	55
16	Review of Infectious Diseases Applications for iPhone/iPad and Android: From Pocket to Patient 2013 ·Clinical Infectious Diseases ·(unknown), Julie E. Mangino, Debra A. Goff	35
17	Improving the management of candidemia through antimicrobial stewardship interventions 2013 ·Diagnostic Microbiology and Infectious Disease ·Erica Reed, Jessica E. West, (unknown), Preeti Pancholi, Joan-Miquel Balada-Llasat, Julie E. Mangino, Karri A. Bauer, Debra A. Goff	53
18	Is the "Low-Hanging Fruit" Worth Picking for Antimicrobial Stewardship Programs? 2012 ·Clinical Infectious Diseases ·Debra A. Goff, Karri A. Bauer, Erica Reed, Kurt Stevenson, (unknown), Jessica E. West	77
19	Carbapenem stewardship: does ertapenem affect Pseudomonas susceptibility to other carbapenems? A review of the evidence 2011 ·International Journal of Antimicrobial Agents ·David P. Nicolau, Yehuda Carmeli, Christopher W. Crank, Debra A. Goff, Christopher J. Graber, Ana Lúcia Lei Munhoz Lima, Ellie J. C. Goldstein	52
20	Impact of a Clinical Pharmacist on Antibiotic Prescribing 1991 ·Journal of Pharmacy Technology ·(unknown), Debra A. Goff, Rebecca Segal, Jean‐Baptiste Guy	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact